{"altmetric_id":18779804,"selected_quotes":["Sensorion $ALSEN SENS-111 phase 2 in acute unilateral vestibulopathies - enrollment started","Sensorion $ALSEN SENS-111 phase 2 in vertigo crisis appears on clinical trial registry (enrollment not started yet)"],"citation":{"altmetric_jid":"clinicaltrialsgov","authors":["Sensorion"],"first_seen_on":"2017-04-12T18:04:57+00:00","issns":[],"journal":"ClinicalTrials.gov","last_mentioned_on":1498257670,"links":["https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03110458"],"nct_id":"NCT03110458","pubdate":"2017-03-27T00:00:00+00:00","publisher":"ClinicalTrials.gov","title":"Efficacy of SENS-111 in Patients Suffering From Acute Unilateral Vestibulopathy (SENS 111-201)","type":"clinical_trial_study_record"},"altmetric_score":{"score":2.8,"score_history":{"1y":2.8,"6m":2.8,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":2.8},"context_for_score":{"all":{"total_number_of_other_articles":8414405,"mean":7.0824487780638,"rank":3358524,"this_scored_higher_than_pct":60,"this_scored_higher_than":5054904,"rank_type":"exact","sample_size":8414405,"percentile":60},"similar_age_3m":{"total_number_of_other_articles":251433,"mean":13.024473631041,"rank":91627,"this_scored_higher_than_pct":63,"this_scored_higher_than":159766,"rank_type":"exact","sample_size":251433,"percentile":63},"this_journal":{"total_number_of_other_articles":24805,"mean":10.526039025964,"rank":8957,"this_scored_higher_than_pct":63,"this_scored_higher_than":15845,"rank_type":"exact","sample_size":24805,"percentile":63},"similar_age_this_journal_3m":{"total_number_of_other_articles":758,"mean":9.9190752972259,"rank":128,"this_scored_higher_than_pct":83,"this_scored_higher_than":630,"rank_type":"exact","sample_size":758,"percentile":83}}},"demographics":{"poster_types":{"member_of_the_public":3,"researcher":1},"users":{"twitter":{"cohorts":{"Members of the public":3,"Scientists":1}}},"geo":{"twitter":{"FR":2,"RE":1}}},"counts":{"total":{"posts_count":5},"twitter":{"unique_users_count":4,"unique_users":["BiotechRadar","Durableo","citoyen974","rypto"],"posts_count":5}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/BiotechRadar\/statuses\/852220966222647297","license":"gnip","citation_ids":[18779804],"posted_on":"2017-04-12T18:04:46+00:00","author":{"name":"Biotech Radar","image":"https:\/\/pbs.twimg.com\/profile_images\/693444152265146369\/T6cOJomc_normal.png","description":"Anticipate the catalysts of EU biotechs (focus on FR\/BE\/NL\/DE listed in Paris\/Bru.\/Ams.).Views=owner's only.RT\/like =\/= endorsement","id_on_source":"BiotechRadar","tweeter_id":"3142088601","geo":{"lt":46,"ln":2,"country":"FR"},"followers":2561},"tweet_id":"852220966222647297"},{"url":"http:\/\/twitter.com\/Durableo\/statuses\/852228591517671427","license":"gnip","rt":["BiotechRadar"],"citation_ids":[18779804],"posted_on":"2017-04-12T18:35:04+00:00","author":{"name":"ecogreenwriter","image":"https:\/\/pbs.twimg.com\/profile_images\/557624687400714240\/GZBvc7Bn_normal.jpeg","description":"Epicurien, \u00e9colo fan d'\u00e9co, Smart Investor (cot\u00e9 et non-cot\u00e9), Supporter du Stade Toulousain. Inside Sales EMEA @ Hitachi Chemicals Energy Tech (CSB Battery)","id_on_source":"Durableo","tweeter_id":"112404192","geo":{"lt":null,"ln":null},"followers":394},"tweet_id":"852228591517671427"},{"url":"http:\/\/twitter.com\/BiotechRadar\/statuses\/878253709934854144","license":"gnip","citation_ids":[18779804],"posted_on":"2017-06-23T14:09:36+00:00","author":{"name":"Biotech Radar","image":"https:\/\/pbs.twimg.com\/profile_images\/693444152265146369\/T6cOJomc_normal.png","description":"Anticipate the catalysts of EU biotechs (focus on FR\/BE\/NL\/DE listed in Paris\/Bru.\/Ams.).Views=owner's only.RT\/like =\/= endorsement","id_on_source":"BiotechRadar","tweeter_id":"3142088601","geo":{"lt":46,"ln":2,"country":"FR"},"followers":2561},"tweet_id":"878253709934854144"},{"url":"http:\/\/twitter.com\/citoyen974\/statuses\/878292753540669440","license":"gnip","rt":["BiotechRadar"],"citation_ids":[18779804],"posted_on":"2017-06-23T16:44:44+00:00","author":{"name":"citoyen & vilain","image":"https:\/\/pbs.twimg.com\/profile_images\/682994528807170049\/kBkCIHai_normal.jpg","description":"vilain fonctionnaire et prof en plus !!!!","id_on_source":"citoyen974","tweeter_id":"470905647","geo":{"lt":-20.88231,"ln":55.4504,"country":"RE"},"followers":196},"tweet_id":"878292753540669440"},{"url":"http:\/\/twitter.com\/rypto\/statuses\/878382452619845632","license":"gnip","rt":["BiotechRadar"],"citation_ids":[18779804],"posted_on":"2017-06-23T22:41:10+00:00","author":{"name":"Daniel De Oliveira","url":"http:\/\/linkedin.com\/in\/daniel-de-oliveira-b13b96138","image":"https:\/\/pbs.twimg.com\/profile_images\/3259766769\/e2eddbd8961f9ff3feca2360dcae6d46_normal.jpeg","description":"Enigmatique mais parfois perceptible... Moi affermi ? Non... Ici comme dans la vie, ne me prends pas toujours au s\u00e9rieux. Chef d'entreprise, Market addict.","id_on_source":"rypto","tweeter_id":"49355508","geo":{"lt":46.81667,"ln":1.7,"country":"FR"},"followers":694},"tweet_id":"878382452619845632"}]}}